Anavex Life Sciences Corp (AVXL)

[Steady_T]

The basics haven't changed that much.

There is still just one trial with a very small number of subjects that has mixed results. Some very good, others looking like little effect. The company hasn't released enough data to really tease out what has happened.

Yes, there are now two trials approved to start and the first subject has been recruited.

What that means is the process to acquire the hard data to demonstrate a working drug to a skeptical bio investor crowd is now underway.

Because of the very high failure rate of AD drugs, most bio investors see the glass as half empty and leaking. It will take clear statistical evidence under a fully controlled trail to convince them to take the risk and invest.

Those of us who are closer to the Anavex 2-73 story see the glass as half full and slowly filling. There is a tendency to over interpret any available information in the most positive light because we want avxl to succeed and there are some very positive pieces of information available.

We current avxl investors are a minority of bio investors and apparently have a higher risk tolerance or deniance level than the majority of bio investors.

That and there is a large short position out there.